Pathstone Holdings LLC Sells 899 Shares of CME Group Inc. (NASDAQ:CME)

Pathstone Holdings LLC decreased its position in CME Group Inc. (NASDAQ:CME) by 2.3% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 38,540 shares of the financial services provider’s stock after selling 899 shares during the period. Pathstone Holdings LLC’s holdings in CME Group were worth $8,504,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently modified their holdings of the company. Ameriprise Financial Inc. boosted its holdings in shares of CME Group by 11.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after buying an additional 537,758 shares during the last quarter. GUARDCAP ASSET MANAGEMENT Ltd raised its position in CME Group by 1.1% in the first quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 4,009,068 shares of the financial services provider’s stock worth $863,112,000 after acquiring an additional 43,293 shares during the period. Raymond James & Associates boosted its stake in CME Group by 3.2% in the second quarter. Raymond James & Associates now owns 3,029,145 shares of the financial services provider’s stock valued at $595,530,000 after acquiring an additional 94,302 shares during the last quarter. Legal & General Group Plc grew its position in shares of CME Group by 6.6% during the 2nd quarter. Legal & General Group Plc now owns 2,835,075 shares of the financial services provider’s stock valued at $557,371,000 after acquiring an additional 176,004 shares during the period. Finally, PineStone Asset Management Inc. increased its stake in shares of CME Group by 137.6% during the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock worth $444,443,000 after purchasing an additional 1,309,097 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Down 0.5 %

CME opened at $226.96 on Friday. The firm has a market capitalization of $81.79 billion, a P/E ratio of 23.87, a price-to-earnings-growth ratio of 5.30 and a beta of 0.55. CME Group Inc. has a one year low of $190.70 and a one year high of $230.74. The company has a fifty day moving average price of $223.40 and a 200-day moving average price of $210.92. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same period in the previous year, the business earned $2.25 earnings per share. The firm’s revenue was up 18.4% on a year-over-year basis. Equities research analysts expect that CME Group Inc. will post 10.22 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be paid a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.03%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio is currently 48.37%.

Insider Activity

In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This represents a 12.01 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Martin J. Gepsman sold 400 shares of CME Group stock in a transaction on Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the transaction, the director now owns 25,067 shares in the company, valued at approximately $5,587,935.64. The trade was a 1.57 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,621 shares of company stock worth $3,441,063. 0.30% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Bank of America increased their price objective on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a report on Thursday, October 3rd. Redburn Atlantic downgraded CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price target for the company. in a research note on Tuesday, October 8th. Citigroup boosted their price objective on CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a research note on Thursday, October 24th. Morgan Stanley increased their target price on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 17th. Finally, The Goldman Sachs Group boosted their price target on shares of CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research report on Thursday, October 3rd. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, CME Group presently has a consensus rating of “Hold” and an average price target of $224.47.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.